Language selection

Search

Declaring monetary value and units sold under Canada's Access to Medicines Regime Within 15 days of the day on which the compulsory licence was granted or the supply agreement was signed, whichever is later, the pharmaceutical company must complete and submit to the patent holder and the Commissioner of Patents a "Solemn or Statutory Declaration Under Paragraph 21.16(1)(b) of the Patent Act". 2020-09-17 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCanada's Access to Medicines Regimedeclaring monetary value and units soldcompulsory licencesupply agreement Declaring monetary value and units sold under Canada's Access to Medicines RegimeHTML https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/companies/forms/declaring-monetary-value-units-sold.html Declaring monetary value and units sold under Canada's Access to Medicines RegimeHTML https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/entreprises/formulaires/declaration-valeur-monetaire-nombre-unites-vendues.html

Declaring monetary value and units sold under Canada's Access to Medicines Regime

Within 15 days of the day on which the compulsory licence was granted or the supply agreement was signed, whichever is later, the pharmaceutical company must complete and submit to the patent holder and the Commissioner of Patents a "Solemn or Statutory Declaration Under Paragraph 21.16(1)(b) of the Patent Act".

Resources

Resource Name Resource Type Format Language Links
Declaring monetary value and units sold under Canada's Access to Medicines Regime Publication HTML English Access
Declaring monetary value and units sold under Canada's Access to Medicines Regime Publication HTML French Access
Similar records